TRACON Pharmaceuticals Inc – Analysts at Jefferies Group upped their Q1 2017 earnings estimates for shares of TRACON Pharmaceuticals in a research note issued to investors on Wednesday. Jefferies Group analyst B. Abrahams now forecasts that the brokerage will earn per share for the quarter, up from their prior estimate of .